Cryo-electron microscopy structures of chimeric hemagglutinin displayed on a universal influenza vaccine candidate

mBio

Volumn 7, Issue 2, 2016, Pages

  Tran, Erin E H ^a   Podolsky, Kira A ^a   Bartesaghi, Alberto ^a   Kuybeda, Oleg ^a   Grandinetti, Giovanna ^a   Wohlbold, Teddy John ^b   Tan, Gene S ^b   Nachbagauer, Raffael ^b,c   Palese, Peter ^b   Krammer, Florian ^b   Subramaniam, Sriram ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; HEMAGGLUTININ; INFLUENZA VACCINE; H1N1 VIRUS HEMAGGLUTININ; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; HYBRID PROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; PROTEIN BINDING; VIRUS ANTIBODY;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CONFORMATION; CRYOELECTRON MICROSCOPY; EMBRYO; IMMUNE RESPONSE; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H5N1); MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; THREE DIMENSIONAL IMAGING; VIRUS STRAIN; GENETICS; INFLUENZA A VIRUS; METABOLISM; MOLECULAR MODEL; ULTRASTRUCTURE;

ANTIBODIES, VIRAL; CRYOELECTRON MICROSCOPY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS; INFLUENZA VACCINES; MODELS, MOLECULAR; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS;

EID: 84965127880     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00257-16     Document Type: Article

References (31)

1. World Health Organization. 2008. Influenza immunization, vaccines and biologicals. World Health Organization, Geneva, Switzerland. http://www.who.int/immunization/topics/influenza/en/.
2. Wiersma LC, Rimmelzwaan GF, de Vries RD. 2015. Developing universal influenza vaccines: hitting the nail, not just on the head. Vaccines (Basel) 3:239–262. http://dx.doi.org/10.3390/vaccines3020239.
3. Treanor JJ. 2015. Prospects for broadly protective influenza vaccines. Vaccine 33:D39–D45. http://dx.doi.org/10.1016/j.vaccine.2015.08.053.
4. Sridhar S, Brokstad KA, Cox RJ. 2015. Influenza vaccination strategies: comparing inactivated and live attenuated influenza vaccines. Vaccines (Basel) 3:373–389. http://dx.doi.org/10.3390/vaccines3020373.
5. Gerdil C. 2003. The annual production cycle for influenza vaccine. Vaccine 21:1776–1779. http://dx.doi.org/10.1016/S0264-410X(03)00071-9.
6. Krammer F, Palese P. 2013. Influenza virus hemagglutinin stalk-based antibodies and vaccines. Curr Opin Virol 3:521–530. http://dx.doi.org/10.1016/j.coviro.2013.07.007.
7. Krammer F, Palese P. 2014. Universal influenza virus vaccines: need for clinical trials. Nat Immunol 15:3–5. http://dx.doi.org/10.1038/ni.2761.
8. Krammer F, Palese P. 2015. Advances in the development of influenza virus vaccines. Nat Rev Drug Discov 14:167–182. http://dx.doi.org/10.1038/nrd4529.
9. Hai R, Krammer F, Tan GS, Pica N, Eggink D, Maamary J, Margine I, Albrecht RA, Palese P. 2012. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J Virol 86:5774–5781. http://dx.doi.org/10.1128/JVI.00137-12.
10. Nachbagauer R, Wohlbold TJ, Hirsh A, Hai R, Sjursen H, Palese P, Cox RJ, Krammer F. 2014. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. J Virol 88:13260–13268. http://dx.doi.org/10.1128/JVI.02133-14.
11. Pica N, Hai R, Krammer F, Wang TT, Maamary J, Eggink D, Tan GS, Krause JC, Moran T, Stein CR, Banach D, Wrammert J, Belshe RB, García-Sastre A, Palese P. 2012. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A 109:2573–2578. http://dx.doi.org/10.1073/pnas.1200039109.
12. Krammer F, Pica N, Hai R, Margine I, Palese P. 2013. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J Virol 87:6542-6550. http://dx.doi.org/10.1128/JVI.00641-13.
13. Moody MA, Zhang R, Walter EB, Woods CW, Ginsburg GS, McClain MT, Denny TN, Chen X, Munshaw S, Marshall DJ, Whitesides JF, Drinker MS, Amos JD, Gurley TC, Eudailey JA, Foulger A, DeRosa KR, Parks R, Meyerhoff RR, Yu JS, Kozink DM, Barefoot BE, Ramsburg EA, Khurana S, Golding H, Vandergrift NA, Alam SM, Tomaras GD, Kepler TB, Kelsoe G, Liao HX, Haynes BF. 2011. H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. PLoS One 6:e25797. http://dx.doi.org/10.1371/journal.pone.0025797.
14. Margine I, Krammer F, Hai R, Heaton NS, Tan GS, Andrews SA, Runstadler JA, Wilson PC, Albrecht RA, García-Sastre A, Palese P. 2013. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses. J Virol 87:10435–10446. http://dx.doi.org/10.1128/JVI.01715-13.
15. Krammer F, Hai R, Yondola M, Tan GS, Leyva-Grado VH, Ryder AB, Miller MS, Rose JK, Palese P, García-Sastre A, Albrecht RA. 2014. Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. J Virol 88:3432–3442. http://dx.doi.org/10.1128/JVI.03004-13.
16. Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, Cinatl J, ter Meulen J, Lasters I, Carsetti R, Peiris M, de Kruif J, Goudsmit J. 2008. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM memory B cells. PLoS One 3:e3942. http://dx.doi.org/10.1371/journal.pone.0003942.
17. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, Goudsmit J, Wilson IA. 2009. Antibody recognition of a highly conserved influenza virus epitope. Science 324:246–251. http://dx.doi.org/10.1126/science.1171491.
18. Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen LM, Santelli E, Stec B, Cadwell G, Ali M, Wan H, Murakami A, Yammanuru A, Han T, Cox NJ, Bankston LA, Donis RO, Liddington RC, Marasco WA. 2009. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16:265–273. http://dx.doi.org/10.1038/nsmb.1566.
19. Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, Ophorst C, Cox F, Korse HJ, Brandenburg B, Vogels R, Brakenhoff JP, Kompier R, Koldijk MH, Cornelissen LA, Poon LL, Peiris M, Koudstaal W, Wilson IA, Goudsmit J. 2011. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333:843–850. http://dx.doi.org/10.1126/science.1204839.
20. Tan GS, Krammer F, Eggink D, Kongchanagul A, Moran TM, Palese P. 2012. A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J Virol 86:6179–6188. http://dx.doi.org/10.1128/JVI.00469-12.
21. Liu J, Bartesaghi A, Borgnia MJ, Sapiro G, Subramaniam S. 2008. Molecular architecture of native HIV-1 gp120 trimers. Nature 455: 109–113. http://dx.doi.org/10.1038/nature07159.
22. White TA, Bartesaghi A, Borgnia MJ, Meyerson JR, de la Cruz MJ, Bess JW, Nandwani R, Hoxie JA, Lifson JD, Milne JL, Subramaniam S. 2010. Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog 6:e1001249. http://dx.doi.org/10.1371/journal.ppat.1001249.
23. Tran EE, Borgnia MJ, Kuybeda O, Schauder DM, Bartesaghi A, Frank GA, Sapiro G, Milne JL, Subramaniam S. 2012. Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog 8:e1002797. http://dx.doi.org/10.1371/journal.ppat.1002797.
24. Chen CJ, Ermler ME, Tan GS, Krammer F, Palese P, Hai R. 13 January 2016. Influenza A viruses expressing intra- or inter-group chimeric hemagglutinins. J Virol http://dx.doi.org/10.1128/JVI.03060-15.
25. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, Vanzetta F, Silacci C, Fernandez-Rodriguez BM, Agatic G, Bianchi S, Giacchetto-Sasselli I, Calder L, Sallusto F, Collins P, Haire LF, Temperton N, Langedijk JP, Skehel JJ, Lanzavecchia A. 2011. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333:850–856. http://dx.doi.org/10.1126/science.1205669.
26. Henry Dunand CJ, Leon PE, Kaur K, Tan GS, Zheng NY, Andrews S, Huang M, Qu X, Huang Y, Salgado-Ferrer M, Ho IY, Taylor W, Hai R, Wrammert J, Ahmed R, García-Sastre A, Palese P, Krammer F, Wilson PC. 2015. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. J Clin Invest 125:1255–1268. http://dx.doi.org/10.1172/JCI74374.
27. Kremer JR, Mastronarde DN, McIntosh JR. 1996. Computer visualization of three-dimensional image data using IMOD. J Struct Biol 116: 71–76. http://dx.doi.org/10.1006/jsbi.1996.0013.
28. Tran EE, Simmons JA, Bartesaghi A, Shoemaker CJ, Nelson E, White JM, Subramaniam S. 2014. Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography. J Virol 88:10958–10962. http://dx.doi.org/10.1128/JVI.00870-14.
29. Kuybeda O, Frank GA, Bartesaghi A, Borgnia M, Subramaniam S, Sapiro G. 2013. A collaborative framework for 3D alignment and classification of heterogeneous subvolumes in cryo-electron tomography. J Struct Biol 181:116–127. http://dx.doi.org/10.1016/j.jsb.2012.10.010.
30. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Wilson IA. 2010. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328:357–360.
31. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. 2006. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404–410.